Ophira Ginsburg, MD
Medical oncologist Ophira Ginsburg, MD, has joined New York University (NYU) Langone’s Perlmutter Cancer Center as Director of its new High Risk Program, which identifies, studies, and cares for patients with hereditary syndromes that increase cancer risk.
Dr. Ginsburg also holds a faculty appointment in the medical center’s Department of Population Health, where she is further developing her global cancer control research focusing on cancer disparities in North America as well as in low- and middle-income countries. Her efforts to improve cancer outcomes—particularly for women—in underserved populations began in 2004 and led her to the World Health Organization Headquarters in Geneva, where she served as Medical Officer for Cancer Control from 2015–2016.
Dr. Ginsburg’s clinical interests are in hereditary cancer predisposition and clinical guidance for risk-reduction strategies. In her previous appointments at the University of Toronto, and as Director of a cancer genetics program there for the past 10 years, she and her team helped families understand their risks for developing cancer and shaped provincial policies for cancer genetics testing and risk-reduction strategies for high-risk women and men.
Dr. Ginsburg earned her medical degree from Queen’s University. She completed her residency training in internal medicine and medical oncology at the University of Toronto and served a postdoctoral fellowship in epidemiology and statistics at the Campbell Family Institute for Breast Cancer at the Ontario Cancer Institute. She has published widely on cancer genetics, breast cancer epidemiology, and global cancer control.
“I’m thrilled to join the faculty of NYU Langone,” Dr. Ginsburg said. “Perlmutter Cancer Center is one of the best cancer centers in the United States. The diversity, interdisciplinary collaboration, and intersection of cancer care and public health, through its work with the Department of Population Health, make this the best place to be.” ■
